Epstein Secrets

C World News Tonight <https://playvideo.bulletinintelligence.corn/bf8faa812b484ed0b4f6c615238318a67pubid=fbi> (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as ea

n a little town near Milan, in the northern region of Lombardy." But the Italian researchers' findings, "published by the INT's scientific magazine Tumori Journal, show that 11.6% of 959 healthy volunteers enrolled in a lung cancer screening trial between September 2019 and March 2020, had developed coronaviru

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

n a little town near Milan, in the northern region of Lombardy." But the Italian researchers' findings, "published by the INT's scientific magazine Tumori Journal, show that 11.6% of 959 healthy volunteers enrolled in a lung cancer screening trial between September 2019 and March 2020, had developed coronavir

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

n a little town near Milan, in the northern region of Lombardy." But the Italian researchers' findings, "published by the INT's scientific magazine Tumori Journal, show that 11.6% of 959 healthy volunteers enrolled in a lung cancer screening trial between September 2019 and March 2020, had developed coronavir

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

n a little town near Milan, in the northern region of Lombardy." But the Italian researchers' findings, "published by the INT's scientific magazine Tumori Journal, show that 11.6% of 959 healthy volunteers enrolled in a lung cancer screening trial between September 2019 and March 2020, had developed coronavir